Case Study: Almirall achieves streamlined clinical data management and regulatory compliance with JMP Clinical

Innovations in clinical research offer opportunities and challenges

Almirall, a global skin health-focused pharmaceutical company, needed a better way to manage rapidly growing clinical trial data while meeting stricter regulatory and patient-safety requirements across its network of affiliates and study partners. The company had previously relied on PDF listings for data review, which became impractical for larger, pivotal studies, especially as it shifted toward risk-based monitoring. JMP Clinical helped Almirall move to a more efficient, digital approach.

JMP implemented JMP Clinical to enable integrated patient data access, targeted data review, alerts for key parameters, and shared Notes for documentation and compliance. As a result, Almirall improved collaboration, detected outliers and protocol deviations earlier, reduced regulatory burden, and streamlined data governance across pre-clinical and clinical data, helping support more efficient study teams and better compliance with global standards.

Almirall

Merce de Frias

International Clinical Trial Manager